Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
about
The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case reportMultilocus analysis of SNP and metabolic data within a given pathway.Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerMeasurement of breast density with digital breast tomosynthesis--a systematic reviewThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityUltrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.Cyclooxygenase-2 and the inflammogenesis of breast cancer.Effects of postnatal exposure to a mixture of polychlorinated biphenyls, p,p'-dichlorodiphenyltrichloroethane, and p-p'-dichlorodiphenyldichloroethene in prepubertal and adult female Sprague-Dawley rats.Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genesMechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens.CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies.Genetics of endometrial cancersPotential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability.Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.What are the main considerations for bioanalysis of estrogens and androgens in plasma and serum samples from postmenopausal women?Urine biomarkers of risk in the molecular etiology of breast cancer.Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer.Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat modelFormation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol.Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.The molecular etiology of breast cancer: evidence from biomarkers of risk.Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cellsConstruction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Circulating sex steroids and breast cancer risk in premenopausal women.Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10.Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cellsThe etiology and prevention of breast cancerThe discovery and mechanism of action of letrozole.Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.DNA repair gene variants associated with benign breast disease in high cancer risk women.
P2860
Q24801958-AD174579-8E6A-4C9D-A6B8-B2BBCF8C594BQ25256821-6C6C7494-69F1-4823-9780-965DB202127AQ26738987-85165293-AB53-4051-ADF9-471DC36935CCQ27008091-502D3897-4C13-4B23-A888-A532E8291030Q27021258-F7A4684D-51CF-4C5C-A306-7A5B6B29B6ADQ30360030-DF7388A5-FB01-4A50-B3D6-14DE097C29B2Q30367680-4AF6D886-98CB-4FA5-9236-2DEB6BB07BB3Q33220095-62491DC5-ACDE-4B0F-9851-4BB5A7D725ECQ33396534-34428BF1-19B1-4D5C-87EC-BFFC2D76AAB1Q33422906-C41802CE-F39F-46E7-8074-C73897A203FCQ33623628-C7D897D1-FD45-4C06-A4DB-AC3EABE45D8BQ33711108-95DE8116-CE16-4BCB-92F8-51ACE0F9D346Q33755530-A806E10B-E14B-4F1F-ABBB-64B44515FB00Q33781274-06ADD39C-0659-4C69-9E11-C83BDA577962Q33786755-DE6D1658-690C-4639-852C-65419F3A7867Q33976413-0A03B4F0-D919-4F5D-A65B-D48AB2B16E99Q34126089-E942FC35-2167-4033-ADAE-C425928129B3Q34154297-7AB8B1ED-6182-44C5-B162-9BD596B48B04Q34383204-A7881A12-EB54-438C-BCA0-6A57A65891B6Q34570111-281C7D23-C230-4B61-8EF9-1A2A80DF3BDAQ34782262-D0EF0197-C9E0-46A9-9AE1-05F8161E6536Q34908964-A2B6CE61-9150-415C-B0A1-B3C7C17F1827Q35083639-45413462-D47D-4E56-A8D4-1000E9AB2333Q35154503-5E8A90F0-1C11-46D0-BE8E-E42AD6C3EDFFQ35389204-4DC31360-AB8B-41BA-9764-E5CB85D154E5Q35575581-4966DB8D-7E2D-4E11-A1A8-239658F6AB9BQ35575724-5345108E-0B51-4869-9CBB-5ECEA4DDE772Q35576611-DB1EF936-184A-435F-8088-1BD7D5101FBCQ35580183-D9AB8C1C-1AA3-4625-86E4-A3E27FE9F3D4Q35586128-F378DC8B-07B0-4EDB-8F54-626F2C63782CQ35593300-1DAF50C7-AF53-4621-A3D9-4947DEFEC1F0Q35659606-8C15C83E-5650-4B0C-826E-475A6C57BDABQ35691729-398668E2-3BB7-465D-9798-2C31B612AFD5Q35729908-86279D7E-BD63-4A48-A59B-38DBDDC596B4Q35808483-492E50BA-C974-42DC-834E-1A60635F5E63Q35910615-A05943CA-EAA2-4C05-B705-3201AE43E784Q36026408-19B55ACB-1279-4C59-87D8-CAD3BA3EC958Q36158553-E4E8CD68-A637-40E5-A756-A28D34BBBBC0Q36173540-EEF6B055-9E14-4EA1-81D3-9FC7B092A4B7Q36190514-B031E8C3-0CAD-467E-B3CD-11E908794230
P2860
Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@ast
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@en
type
label
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@ast
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@en
prefLabel
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@ast
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@en
P2093
P1476
Genotoxic metabolites of estra ...... radiol induced carcinogenesis.
@en
P2093
Bocchinfuso WP
Cavalieri EL
Devanesan P
Todorovic R
Verderame MF
P304
P356
10.1016/S0960-0760(03)00377-7
P577
2003-09-01T00:00:00Z